These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9686500)

  • 1. [Levels of procollagen type III n-terminal peptide (PIIINP) in serum of patients with myeloproliferative syndrome (mps)].
    Podolak-Dawidziak M; Wróbel T; Jeleń M
    Pol Arch Med Wewn; 1998 Jan; 99(1):24-9. PubMed ID: 9686500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procollagen type III aminoterminal peptide in serum in idiopathic myelofibrosis and allied conditions: relation to disease activity and effect of chemotherapy.
    Hasselbalch H; Junker P; Hørslev-Petersen K; Lisse I; Bentsen KD
    Am J Hematol; 1990 Jan; 33(1):18-26. PubMed ID: 2293759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of multiple myeloma and bone marrow fibrosis with aminoterminal propeptide of type III collagen (PIIINP).
    Taube T; Franssila K; Risteli L; Risteli J; Elomaa I
    Br J Haematol; 1992 Sep; 82(1):32-7. PubMed ID: 1419800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating hyaluronan in the myelofibrosis/osteomyelosclerosis syndrome and other myeloproliferative disorders.
    Hasselbalch H; Junker P; Lisse I; Lindqvist U; Engström Laurent A
    Am J Hematol; 1991 Jan; 36(1):1-8. PubMed ID: 1984676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum procollagen III peptide in chronic myeloproliferative disorders.
    Hasselbalch H; Junker P; Lisse I; Bentsen KD
    Scand J Haematol; 1985 Nov; 35(5):550-7. PubMed ID: 4089533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow fibrosis and disease activity in multiple myeloma monitored by the aminoterminal propeptide of procollagen III in serum.
    Abildgaard N; Bendix-Hansen K; Kristensen JE; Vejlgaard T; Risteli L; Nielsen JL; Heickendorff L
    Br J Haematol; 1997 Dec; 99(3):641-8. PubMed ID: 9401078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum laminin P1 in idiopathic myelofibrosis and related diseases.
    Hasselbalch H; Junker P
    Leuk Res; 1994 Aug; 18(8):623-8. PubMed ID: 8065164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased serum procollagen III aminoterminal peptide in myelofibrosis.
    Hochweiss S; Fruchtman S; Hahn EG; Gilbert H; Donovan PB; Johnson J; Goldberg JD; Berk PD
    Am J Hematol; 1983 Dec; 15(4):343-51. PubMed ID: 6650494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collagen metabolism and enzymes of the urokinase plasminogen activator system in chronic myeloproliferative disorders: correlation between plasma-soluble urokinase plasminogen activator receptor and serum markers for collagen metabolism.
    Jensen MK; Riisbro R; Holten-Andersen MN; Brown Pde N; Junker P; Brünner N; Hasselbalch HC
    Eur J Haematol; 2003 Oct; 71(4):276-82. PubMed ID: 12950237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum aminoterminal peptide of type III procollagen (PIIINP) and transforming growth factor-beta1 (TGF-beta1) levels in patients with chronic hepatitis B and C].
    Marek B; Kajdaniuk D; Janczewska-Kazek E; Beniowski M; Swietochowska E; Kos-Kudła B; Ostrowska Z; Mazurek U; Wilczok T; Nowak M; Siemińska L; Borgiel-Marek H; Strzyzewski A; Januła A; Sierek K; Niedzielski Z
    Pol Arch Med Wewn; 2003 Jun; 109(6):603-8. PubMed ID: 14567092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The influence of heart infarction on the concentration of aminoterminal type III procollagen peptide in blood serum].
    Jonderko G; Kucharz EJ; Fink M; Filipek B; Kotrys-Puchalska E; Wedrychowska A
    Pol Arch Med Wewn; 1996 Dec; 96(6):520-7. PubMed ID: 9139271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum concentration of amino-terminal propeptide of type III procollagen (PIIINP) as a prognostic marker for skin fibrosis after scar correction in burned patients.
    Ulrich D; Noah EM; Burchardt ER; Atkins D; Pallua N
    Burns; 2002 Dec; 28(8):766-71. PubMed ID: 12464475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
    Maurice PD; Maddox AJ; Green CA; Tatnall F; Schofield JK; Stott DJ
    Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different effects of thyroid disease on serum levels of procollagen III N-peptide and hyaluronic acid.
    Faber J; Hørslev-Petersen K; Perrild H; Lorenzen I
    J Clin Endocrinol Metab; 1990 Oct; 71(4):1016-21. PubMed ID: 2401705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum markers for type IV collagen and type III procollagen in the myelofibrosis-osteomyelosclerosis syndrome and other chronic myeloproliferative disorders.
    Hasselbalch H; Junker P; Lisse I; Bentsen KD; Risteli L; Risteli J
    Am J Hematol; 1986 Oct; 23(2):101-11. PubMed ID: 3752065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of polycythemia to myelofibrosis. Monitoring by the assay of the procollagen III amino-propeptide].
    Arrago JP; Poirier O; Najean Y
    Presse Med; 1984 Nov; 13(40):2429-32. PubMed ID: 6239221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum concentrations of laminin P1 and aminoterminal propeptide of type III procollagen in sickle cell disease.
    Bolarin DM; Swerdlow P; Wallace AM; Littsey L
    Haematologia (Budap); 1998; 29(1):51-8. PubMed ID: 9704258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type III procollagen N-terminal propeptide, soluble interleukin-2 receptor, and von Willebrand factor in systemic sclerosis.
    Lee YJ; Shin KC; Kang SW; Lee EB; Kim HA; Song YW
    Clin Exp Rheumatol; 2001; 19(1):69-74. PubMed ID: 11247328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum type-III-procollagen and laminin concentration after interferon therapy in chronic myeloproliferative disorders.
    Sréter L; Kárteszi M; Fehér J; Lutz D
    Acta Med Hung; 1988; 45(3-4):323-8. PubMed ID: 3249659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminoterminal propeptide of type III procollagen in the follow-up of patients with abdominal aortic aneurysms.
    Satta J; Haukipuro K; Kairaluoma MI; Juvonen T
    J Vasc Surg; 1997 May; 25(5):909-15. PubMed ID: 9152320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.